Department of Neurology, Leiden University Medical Center, Leiden and Hagaziekenhuis, The Hague, the Netherlands
Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands
Department of Neurology, Hagaziekenhuis, The Hague, the Netherlands
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
G.M. Terwindt Department of Neurology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, the Netherlands
The relationship between patent foramen ovale (PFO) and migraine is much debated and controversial. Until recently, evidence on PFO closure to reduce migraine was based upon uncontrolled studies only; nevertheless an increasing number of medical specialists consider PFO closure to be a treatment option. We report on the current evidence of PFO closure in migraine, mainly based on the recently published first prospective double-blind, sham-controlled study.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984; 59: 17–20.
Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia. 2008; 28: 531–40.
Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart. 2004; 90: 1315–20.
Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000; 356: 1648–51.
Diener HC, Hartung E, Chrubasik J, Evers S, Schoenen J, Eikermann A, et al. A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia. 2001; 21: 120–8.
Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008; 117: 1397–404.
Dowson AJ, Wilmshurst P, Muir KW, Mullen M, Nightingale S. A Prospective, Multicenter, Randomized, Double Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Patent Foramen Ovale Closure with the STARFlex Septal Repair Implant to Prevent Refractory Migraine Headaches: the MIST Trial: S61.002. Neurology. 2006; 67: 185.
Wood S. MIST published; editorial highlights discrepancies, implications for other migraine trials. News Heartwire 2008 March. Online www.medscape.com (21 April 2008).
Qui J. In search of a migraine cure: a matter of heart and mind. Lancet Neurol. 2008; 7: 576–77.
Dyer C. News: Doctor is sued for comments on potential migraine device. BMJ. 2008; 337: 1076.
- No indication for patent foramen ovale closure in migraine
G. M. Terwindt
S. F. T. M. de Bruijn
J. J. Bax
M. D. Ferrari
- Bohn Stafleu van Loghum
Neu im Fachgebiet Kardiologie
Mail Icon II